Document is current
Any future updates will be listed below
-
Authors
Angulo-Urarte, Ana http://orcid.org/0000-0002-8024-814X
Graupera, Mariona http://orcid.org/0000-0003-4608-4185
- License Information
-
More Information
Article History
Received: 2 April 2022
Accepted: 22 June 2022
First Online: 8 August 2022
Competing interests
: M.G. had a research agreement with Merck & Co. and Venthera to test their inhibitors of the PI3K pathway in vascular malformations.
